secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001104659-25-061184
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals sets 2025 AGM for August 21; shareholder proposal deadline June 30
--------------------------------------------------------------------------------

- 2025 Annual General Meeting scheduled for August 21, 2025.
- Shareholder proposals under Rule 14a-8 must be received by June 30, 2025.
- Notice for proxy solicitations for director nominees other than company's must be given by June 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/0001104659-25-061184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/tm2518339d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer